- 1 ml contains -
- Active ingredient: Haemophilus influenzae type b oligosaccharide 20 g + Diphtheria CRM197 protein 50 g (Biologic STD) ----------- 70 g (Haemophilus influenzae type b Eagan (PBCC 197) strain, Corynebacterium diphtheria C7 (197) strain)
- Isotonic agent : Sodium Chloride (USP) -------------- 9mg
- Vehicle : Water for Injection (USP) ----------------- q.s.
     
   
The immunization of infants and children 2 months to 71 months of age against invasive disease caused by Haemophilus influenzae type b.
     
   
HibTITER should be injected intramuscularly, preferably into the midlateral muscles of the thigh. For infants 2 to 6 months of age, the immunizing dose is three separate injections of 0.5ml given at approximately 2-months intervals. Previously unvaccinated infants from 7 through 11 months of age should receive two separate injections approximately 2 months apart. Children from 12 through 14 months of age who have not been vaccinated previously receive one injection. All vaccinated children receive a single booster dose at 15months of age or older, but not less than 2 months after the previous dose. Previously unvaccinated children 15 to 71 months of age receive a single injection
     
   
0.5ml/vial x 4